The Art of SAPIEN 3 Transcatheter Mitral Valve Replacement in Valve-in-Ring and Valve-in-Mitral-Annular-Calcification Procedures
Overview
Authors
Affiliations
The SAPIEN 3 is the only transcatheter heart valve commercially available for compassionate transcatheter mitral valve replacement in patients with previous mitral surgical rings and mitral annular calcification (valve in ring [VIR] and valve in mitral annular calcification [VIM]). Reported outcomes have been inconsistent or poor. The review provides an overview of the authors' approach to achieve largely consistent results despite the intrinsic limitations of SAPIEN 3 VIM and VIR. The approach includes bedside modifications of the valve implant, the delivery system, and of the cardiac substrate itself. Until purpose-built devices are readily available, VIR and VIM procedures will require aggressive multidisciplinary cooperation, meticulous planning and execution, and postprocedure management by experienced, high-volume operators.
5-Year Outcomes of Anterior Mitral Leaflet Laceration to Prevent Outflow Obstruction.
Khan J, Babaliaros V, Greenbaum A, McCabe J, Rogers T, Eng M JACC Cardiovasc Interv. 2024; 17(18):2157-2167.
PMID: 39243268 PMC: 11424260. DOI: 10.1016/j.jcin.2024.05.041.
Pan Y, Zhou Y, Liu Y, Peng Z, Liu L, Yang Y JTCVS Tech. 2023; 22:28-38.
PMID: 38152208 PMC: 10750836. DOI: 10.1016/j.xjtc.2023.09.006.
Ueyama H, Gleason P, Babaliaros V, Greenbaum A Methodist Debakey Cardiovasc J. 2023; 19(3):37-49.
PMID: 37213881 PMC: 10198232. DOI: 10.14797/mdcvj.1221.
Kohli K, Wei Z, Sadri V, Siefert A, Blanke P, Perdoncin E Front Cardiovasc Med. 2022; 9:869259.
PMID: 35811698 PMC: 9261975. DOI: 10.3389/fcvm.2022.869259.
Redo transcatheter mitral valve replacement in mitral annular calcification.
Jdaidani J, Iskandarani D, Chaabo O, Gharzeddine W, Tang G, Sawaya F EuroIntervention. 2022; 18(9):779-780.
PMID: 35019841 PMC: 10241260. DOI: 10.4244/EIJ-D-21-00871.